The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Merck announced that the FDA approved KEYTRUDA, Merck’s anti-PD-1 therapy, as a single agent, for adjuvant treatment following surgical resection and ...
read more
The Alzheimer's Association appreciates the Food and Drug Administration's (FDA) methodical process in reviewing treatments for Alzheimer's disease.
read more
Dr. Reddy’s Laboratories Ltd. has successfully completed the full set of clinical studies of its proposed rituximab biosimilar candidate, DRL_RI, for ...
read more
Thursday, January 19, 2023
Orthogen AG announced FDA approval of an Investigational Device Exemption (IDE) for the company's proprietary technology, Orthogen® Device (OD).
read more
Wednesday, January 18, 2023
Celltrion Healthcare Canada Limited announced that Health Canada granted a notice of compliance (NOC) on January 3, 2023 for Vegzelma®, a biosimilar ...
read more
Wednesday, January 18, 2023
Evaxion Biotech A/S announced that the FDA granted fast-track designation for the Company’s personalized cancer therapy, EVX-01, in combination with ...
read more
Tuesday, January 17, 2023
Alvotech and Fuji Pharma Co., Ltd. have decided to expand their existing exclusive commercialization partnership covering Japan, by adding a new ...
read more
Tuesday, January 17, 2023
AstraZeneca’s Tezspire (tezepelumab) has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human ...
read more
Tuesday, January 17, 2023
CN Bio announced that the FDA and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS ...
read more
Tuesday, January 17, 2023
THREAD announced a five-year collaboration with, Sanofi. THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and ...
read more
Tuesday, January 10, 2023
BioNTech SE and InstaDeep have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field...
read more
Tuesday, January 10, 2023
Ionis Pharmaceuticals, Inc. (and Royalty Pharma plc announced that Royalty Pharma has acquired an interest in Ionis' royalty in Biogen's SPINRAZA® (...
read more
Tuesday, January 10, 2023
Ajinomoto Co., Inc. announced a license agreement with Exelixis, Inc. to incorporate AJICAP®, Ajinomoto Co.’s proprietary site-specific bioconjugation...
read more
AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, ...
read more
Santhera Pharmaceuticals and ReveraGen BioPharma, Inc. announced that the FDA accepted the new drug application (NDA) for vamorolone for the treatment...
read more